Literature DB >> 85720

Isolation of a nucleocapsid polypeptide of herpes simplex virus types 1 and 2 possessing immunologically type-specific and cross-reactive determinants.

C J Heilman, M Zweig, J R Stephenson, B Hampar.   

Abstract

A polypeptide (p40) of approximately 40,000 molecular weight was isolated from herpes simplex virus type 1 and 2 nucleocapsids by gel filtration and ion exchange chromatography. This protein appears to be the same as protein 22a described previously (Gibson and Roizman, J. Virol. 10:1044--1052, 1972). Competition immunoassays were developed by using purified p40 and antisera prepared in guinea pigs. The assays indicated that the p40's from herpes simplex virus types 1 and 2 possess both type-specific and cross-reactive antigenic determinants. Antibodies to the p40 cross-reactive determinant reacted with antigens in simian herpes virus SA8-infected cells, but not with antigens induced by pseudorabies virus. Preliminary results indicated that a radioimmunoprecipitation test can be used to detect type-specific herpes simplex virus p40 antibodies in human sera.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 85720      PMCID: PMC353066          DOI: 10.1128/JVI.29.1.34-42.1979

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  14 in total

1.  Characterization of three species of nucleocapsids of equine herpesvirus type-1 (EHV-1).

Authors:  M L Perdue; J C Cohen; M C Kemp; C C Randall; D J O'Callaghan
Journal:  Virology       Date:  1975-03       Impact factor: 3.616

2.  THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY.

Authors:  F C GREENWOOD; W M HUNTER; J S GLOVER
Journal:  Biochem J       Date:  1963-10       Impact factor: 3.857

3.  Some structural antigens of herpes simplex virus type 1.

Authors:  K L Powell; D H Watson
Journal:  J Gen Virol       Date:  1975-11       Impact factor: 3.891

4.  Polypeptide synthesized in herpes simplex virus type 2-infected HEp-2 cells.

Authors:  K L Powell; R J Courtney
Journal:  Virology       Date:  1975-07       Impact factor: 3.616

5.  Proteins specified by herpes simplex virus. 8. Characterization and composition of multiple capsid forms of subtypes 1 and 2.

Authors:  W Gibson; B Roizman
Journal:  J Virol       Date:  1972-11       Impact factor: 5.103

6.  Antigens of Herpes simplex virus type 1 and 2-immunodiffusion and inhibition passive hemagglutination studies.

Authors:  K E Schneweis; A J Nahmias
Journal:  Z Immunitatsforsch Exp Klin Immunol       Date:  1971-06

7.  Type specific and type common antigens in cells infected with herpes simplex virus type 1 and on the surfaces of naked and enveloped particles of the virus.

Authors:  R W Honess; K L Powell; D J Robinson; C Sim; D H Watson
Journal:  J Gen Virol       Date:  1974-02       Impact factor: 3.891

8.  Species-specific and interspecific antigenic determinants associated with the structural protein of feline C-type virus.

Authors:  S Oroszlan; R J Huebner; R V Gilden
Journal:  Proc Natl Acad Sci U S A       Date:  1971-05       Impact factor: 11.205

9.  Serologic relationship o a simian Herpes virus (SA8) and Herpes simplex virus: heterogeneity in the degree of reciprocal cross-reactivity shown by rabbit 7S and 19S antibodies.

Authors:  D A Stevens; T Pincus; M A Burroughs; B Hampar
Journal:  J Immunol       Date:  1968-11       Impact factor: 5.422

10.  Studies on herpes simplex virus and cancer.

Authors:  J L Melnick; R J Courtney; K L Powell; P A Schaffer; M B Melnick; G R Dreesman; T Anzai; E Adam
Journal:  Cancer Res       Date:  1976-02       Impact factor: 12.701

View more
  32 in total

1.  Posttranslational modification and subcellular localization of the p12 capsid protein of herpes simplex virus type 1.

Authors:  D S McNabb; R J Courtney
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

2.  The Herpesvirus capsid surface protein, VP26, and the majority of the tegument proteins are dispensable for capsid transport toward the nucleus.

Authors:  Sarah E Antinone; George T Shubeita; Kelly E Coller; Joy I Lee; Sarah Haverlock-Moyns; Steven P Gross; Gregory A Smith
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

3.  Incorporation of the green fluorescent protein into the herpes simplex virus type 1 capsid.

Authors:  P Desai; S Person
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

4.  Identification of precursor to cytomegalovirus capsid assembly protein and evidence that processing results in loss of its carboxy-terminal end.

Authors:  W Gibson; A I Marcy; J C Comolli; J Lee
Journal:  J Virol       Date:  1990-03       Impact factor: 5.103

5.  Hexon-only binding of VP26 reflects differences between the hexon and penton conformations of VP5, the major capsid protein of herpes simplex virus.

Authors:  P T Wingfield; S J Stahl; D R Thomsen; F L Homa; F P Booy; B L Trus; A C Steven
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

6.  Production of monoclonal antibodies against nucleocapsid proteins of herpes simplex virus types 1 and 2.

Authors:  M Zweig; C J Heilman; H Rabin; R F Hopkins; R H Neubauer; B Hampar
Journal:  J Virol       Date:  1979-11       Impact factor: 5.103

7.  Gel electrophoretic analysis of polypeptides from nucleocapsids of Marek's disease virus strains and herpesvirus of turkey.

Authors:  F Westenbrink; J M Brinkhof; A L Gielkens
Journal:  Arch Virol       Date:  1985       Impact factor: 2.574

8.  Simian alphaherpesviruses and their relation to the human herpes simplex viruses.

Authors:  J K Hilliard; D Black; R Eberle
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

9.  Release of the catalytic domain N(o) from the herpes simplex virus type 1 protease is required for viral growth.

Authors:  L Matusick-Kumar; P J McCann; B J Robertson; W W Newcomb; J C Brown; M Gao
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

10.  Flow cytometric indirect immunofluorescence assay with high sensitivity and specificity for the detection of antibodies to HSV-1 and HSV-2.

Authors:  A Caruso; M Tinti; L Peroni; E Cabibbo; C De Rango; N Manca; A Turano
Journal:  Eur J Epidemiol       Date:  1993-09       Impact factor: 8.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.